Sign in
4

Changes in Ownership

Atara Biotherapeutics, Inc. Filed Acc 0001209191-18-047107

EVP, R&D & Chief Scientific Of sold 775 shares at $37.54 ($29,094)

From the SEC's structured data for this filing

Trades in this filing

Haqq Christopher · EVP, R&D & Chief Scientific Of

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2018-08-15 Sale : show line 1 in the form −775 $37.54 $29,094 331,355 D
Open-market sales · 775 sh · avg $37.54 · $29,094
Loading xslF345X03/doc4.xml…